ChromaDex

ChromaDex is a dietary supplement and food ingredient company based in Los Angeles, California founded in 1999 that is publicly traded on the NASDAQ.

ChromaDex, Inc
Public
Traded asNASDAQ: CDXC
Russell 2000 Index component
IndustryDietary supplements, food ingredients
Founded1999
HeadquartersLos Angeles, California, United States
Key people
Rob Fried
(CEO)
Frank Jaksch
(Co-Founder, Executive Chairman)
ProductsTru Niagen
Websitewww.chromadex.com

In 2011, Dartmouth College announced it granted ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside which it markets and sells as an ingredient under the brand name Tru Niagen. The firm also offers contract research services for sourcing raw materials, identifying new compounds, and developing processes for large scale manufacturing.[1] ChromaDex licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line.[2] ChromaDex no longer sells PteroPure.[3]

Elysium Health bought the ingredients in its "Basis" product from ChromaDex.[4] The two firms had an agreement under which Elysium didn't have to acknowledge ChromaDex as the source of the ingredients, but then after Elysium recruited the head of manufacturing from ChromaDex and stopped paying ChromaDex, ChromaDex sued Elysium and the information became public.[5]

References
  1. "OTC Markets Stock Profile CDXC". OTC Markets. Retrieved 2016-03-21.
  2. Neeb, Matthew (2011-06-20). "Ole Miss grants exclusive patent rights to ChromaDex Corp". The Daily Mississippian. Archived from the original on 2012-04-18. Retrieved 2012-05-25.
  3. Krawiec, Sebastian (2018-10-31). "ChromaDex ceases new pterostilbene orders based on research demonstrating increase in LDL cholesterol". Nutritional Outlook. Retrieved 2020-05-01.
  4. Zhang, Sarah (July 6, 2016). "The Weird Business Behind a Trendy "Anti-Aging" Pill". Wired.
  5. Buhr, Sarah (January 16, 2017). "A new lawsuit alleges anti-aging startup Elysium Health hasn't paid its sole supplier". TechCrunch.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.